We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUS icon
1551
ePlus
PLUS
$2.35B
$52K ﹤0.01%
1,520
+1,188
+358% +$49.4K
TEAM icon
1552
Atlassian
TEAM
$38.5B
$52K ﹤0.01%
394
+374
+1,870% +$45.1K
TV icon
1553
Televisa
TV
$1.52B
$52K ﹤0.01%
6,193
+5,993
+2,997% +$58.3K
YPF icon
1554
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$20B
$52K ﹤0.01%
+2,865
New +$44.1K
EIGR
1555
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$52K ﹤0.01%
163
+154
+1,711% +$53.3K
NUVA
1556
DELISTED
NuVasive, Inc.
NUVA
$52K ﹤0.01%
888
+678
+323% +$40K
ASML icon
1557
ASML
ASML
$666B
$51K ﹤0.01%
244
-2,577
-91% -$512K
BOH icon
1558
Bank of Hawaii
BOH
$3.1B
$51K ﹤0.01%
617
-3,184
-84% -$256K
DOX icon
1559
Amdocs
DOX
$6.22B
$51K ﹤0.01%
829
+81
+11% +$4.68K
FIZZ icon
1560
National Beverage
FIZZ
$2.91B
$51K ﹤0.01%
2,296
+2,288
+28,600% +$58.9K
LADR
1561
Ladder Capital
LADR
$1.22B
$51K ﹤0.01%
3,061
-11,990
-80% -$200K
MIST icon
1562
Milestone Pharmaceuticals
MIST
$157M
$51K ﹤0.01%
+1,877
New +$38.7K
NBIX icon
1563
Neurocrine Biosciences
NBIX
$16.8B
$51K ﹤0.01%
595
+246
+70% +$20.2K
PSO icon
1564
Pearson
PSO
$9.89B
$51K ﹤0.01%
4,942
+2,628
+114% +$27.5K
SCHL icon
1565
Scholastic
SCHL
$807M
$51K ﹤0.01%
1,522
+1,346
+765% +$50.2K
VRE
1566
DELISTED
Veris Residential
VRE
$51K ﹤0.01%
+2,196
New +$50.4K
CEM
1567
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$51K ﹤0.01%
+849
New +$52.3K
CADE
1568
DELISTED
Cadence Bancorporation
CADE
$51K ﹤0.01%
2,473
+364
+17% +$7.49K
CE icon
1569
Celanese
CE
$4.88B
$50K ﹤0.01%
460
-4,305
-90% -$446K
DGX icon
1570
Quest Diagnostics
DGX
$26.2B
$50K ﹤0.01%
492
-4,561
-90% -$438K
FNKO icon
1571
Funko
FNKO
$346M
$50K ﹤0.01%
2,082
-137
-6% -$2.91K
KMI icon
1572
Kinder Morgan
KMI
$69.9B
$50K ﹤0.01%
2,382
-43,159
-95% -$870K
KW
1573
DELISTED
Kennedy-Wilson Holdings
KW
$50K ﹤0.01%
+2,450
New +$52.1K
NEWT icon
1574
NewtekOne
NEWT
$372M
$50K ﹤0.01%
2,193
-1,596
-42% -$34.9K
ROK icon
1575
Rockwell Automation
ROK
$48.3B
$50K ﹤0.01%
305
-2,430
-89% -$411K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.